Cabot (NYSE:CBT) Stock Gets Price Target Reduction from UBS Group

Cabot (NYSE:CBT) had its price objective lowered by equities researchers at UBS Group from $86.00 to $80.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a “neutral” rating on the specialty chemicals company’s stock. UBS Group‘s target price would suggest a potential upside of 6.41% from the stock’s previous close.

CBT has been the subject of several other reports. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, October 11th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research note on Friday, August 21st. JPMorgan Chase & Co. lifted their price target on Cabot from $70.00 to $78.00 and gave the company an “underweight” rating in a report on Friday, August 7th. Finally, Truist Financial dropped their price objective on shares of Cabot from $100.00 to $95.00 and set a “buy” rating for the company in a research note on Wednesday. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $85.60.

Cabot Trading Up 4.4%

CBT stock traded up $3.18 during midday trading on Wednesday, hitting $75.18. The stock had a trading volume of 548,996 shares, compared to its average volume of 457,183. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53. The firm has a market cap of $3.88 billion, a PE ratio of 18.75, a price-to-earnings-growth ratio of 8.91 and a beta of 0.83. The company’s 50-day moving average price is $77.55 and its 200 day moving average price is $79.52. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.47 and a quick ratio of 0.97.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.55 by $0.06. The business had revenue of $1.01 billion for the quarter, compared to analysts’ expectations of $927.29 million. Cabot had a return on equity of 19.79% and a net margin of 5.69%. The business’s revenue was up 12.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.70 earnings per share. On average, equities research analysts predict that Cabot will post 7.08 earnings per share for the current fiscal year.

Insider Buying and Selling at Cabot

In other news, CEO Sean Keohane sold 134,895 shares of the business’s stock in a transaction on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,351,390. The trade was a 25.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders have sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Bank of America Corp DE acquired a new stake in Cabot during the second quarter worth about $150,772,000. State Street Corp raised its holdings in shares of Cabot by 6.8% in the 2nd quarter. State Street Corp now owns 2,165,434 shares of the specialty chemicals company’s stock worth $196,665,000 after purchasing an additional 138,098 shares during the period. First Eagle Investment Management LLC raised its holdings in shares of Cabot by 52.5% in the 2nd quarter. First Eagle Investment Management LLC now owns 208,450 shares of the specialty chemicals company’s stock worth $18,931,000 after purchasing an additional 71,800 shares during the period. Lazard Asset Management LLC raised its holdings in shares of Cabot by 96.2% in the 1st quarter. Lazard Asset Management LLC now owns 43,219 shares of the specialty chemicals company’s stock worth $3,255,000 after purchasing an additional 21,194 shares during the period. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Cabot in the 2nd quarter valued at about $1,881,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Trending Headlines about Cabot

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Fiscal Q4 adjusted EPS was $1.61, above the $1.55 consensus, while revenue of $1.01 billion topped estimates of about $927 million. The earnings beat provides a near-term positive, although EPS was below $1.70 a year earlier. Cabot beats Q4 earnings and revenue estimates
• Neutral Sentiment: Truist lowered its price target to $95 from $100 but kept a Buy rating, while UBS cut its target to $80 from $86 and maintained Neutral. The mixed views offer support from Truist’s rating but underscore more cautious target expectations. UBS adjusts Cabot price target
• Negative Sentiment: Cabot forecast fiscal 2027 adjusted EPS of $6.15–$6.75, below the analyst consensus of $7.03. The outlook miss could weigh on expectations despite the latest-quarter beat. Cabot forecasts fiscal 2027 adjusted EPS
• Negative Sentiment: Coverage also cited weaker margins as a reason the stock fell following the earnings release. This suggests profitability concerns are offsetting the stronger-than-expected sales and EPS. Cabot falls despite beating estimates on weaker margins

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.